With the announcement of 'Consistency Evaluation of Quality and Efficacy of Generic Drugs', 'Adjusting the Evaluation and Approval of API, Excipients and Packaging Materials' and related review and approval issued consecutively in China, pharmaceutical enterprises has now the responsibility for the selection of pharmaceutical excipients. Driven by the policy, tremendous challenges and opportunities have burgeoned and key innovations have been fostered in new products, new dosage forms and new technologies among pharmaceutical excipients and packages.
PharmaExcipients China 2019 will be launched at Hall E3 of Shanghai New International Expo Centre from June 18 to 20, 2019. The zone is expected to gather more than 100 global high-quality pharmaceutical excipients enterprises, not only to help enterprises to open up markets in medicine, health care products and other fields, but also to gather global front-line experts and industry authorities together to analyse the updating of excipients guide, to explore the technical requirements of quality control, and to help excipients enterprises integrate into the global industrial chain.
